» Authors » Asim Roy

Asim Roy

Explore the profile of Asim Roy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 91
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ryschon A, Roy A, Pietzsch J
J Med Econ . 2024 Sep; 27(1):1320-1327. PMID: 39340771
Aims: Patients with medication-refractory restless legs syndrome (RLS) have limited therapeutic options available for symptom relief. Tonic motor activation (TOMAC) presents a novel, non-invasive therapy for this patient population. The...
2.
Dauvilliers Y, Roth T, Bogan R, Thorpy M, Morse A, Roy A, et al.
Sleep Med . 2024 Sep; 124:209-216. PMID: 39321628
Objective/background: Extended-release, once-nightly sodium oxybate (ON-SXB) significantly improved narcolepsy symptoms in participants in the phase 3, randomized, double-blind, placebo-controlled REST-ON trial. This post hoc analysis of REST-ON data evaluated ON-SXB...
3.
Roy A, Stern T, Harsh J, Hudson J, Ajayi A, Corser B, et al.
Sleep Med X . 2024 Sep; 8:100122. PMID: 39263597
Objective/background: Preference for extended-release, once-nightly sodium oxybate (ON-SXB, FT218) vs twice-nightly immediate-release (IR) oxybate was assessed in participants switching from IR oxybate to ON-SXB in an open-label/switch study, RESTORE (NCT04451668)....
4.
Huyett P, Yu P, Kent D, Stahl S, Manchanda S, Mehra R, et al.
Laryngoscope . 2024 Aug; 135(1):469-477. PMID: 39162306
Objective: Hypoglossal nerve stimulation (HGNS) is an implantable therapy for obstructive sleep apnea (OSA). Therapy efficacy is currently confirmed by a formal sleep study after empiric adjustment by the patient...
5.
Roth T, Morse A, Bogan R, Roy A, Gudeman J, Dauvilliers Y
Clin Ther . 2024 Aug; 46(10):791-798. PMID: 39153911
Purpose: Individuals with narcolepsy are more likely to be obese than the general population. Changes in weight-related measures with extended-release, once-nightly sodium oxybate (ON-SXB) and characteristics of participants with ≥5%...
6.
Morse A, Bogan R, Roy A, Thorpy M
Neurol Ther . 2024 Apr; 13(3):785-807. PMID: 38662324
Introduction: Low-sodium oxybate (LXB) is approved for treatment of narcolepsy in patients aged 7 years and older and treatment of idiopathic hypersomnia in adults. LXB contains the same active moiety...
7.
Macfadden W, Leary E, Fuller D, Kirby M, Roy A
J Clin Sleep Med . 2024 Apr; 20(9):1467-1477. PMID: 38652499
Study Objectives: Low-sodium oxybate (LXB; calcium, magnesium, potassium, and sodium oxybates; Xywav) contains the same active moiety as high-sodium oxybates (SXBs; SXB [Xyrem] and fixed-dose SXB [Lumryz]), with 92% less...
8.
Dehingia A, Das U, Gogoi H, Borgohain K, Patra S, Paul B, et al.
Small . 2024 Apr; 20(34):e2401179. PMID: 38639026
Although the atmospheric stability of lead-free inorganic double perovskite (DP) solar cells (PSCs) looks promising, their further development is hampered by inadequate film quality and non-radiative carrier recombination at the...
9.
Buchfuhrer M, Roy A, Rodriguez S, Charlesworth J
BMC Neurol . 2023 Nov; 23(1):415. PMID: 37990163
Background: There is a large population of restless legs syndrome (RLS) patients who are refractory to medication. Whereas experts recommend off-label opioids as an effective long-term treatment for refractory RLS,...
10.
Ryschon A, Cao K, Roy A, Pietzsch J
Neurol Ther . 2023 Oct; 12(6):2133-2146. PMID: 37824047
Introduction: Tonic motor activation (TOMAC) therapy is a novel non-pharmacologic treatment approach for patients suffering from medication-refractory restless legs syndrome (RLS). The objective of this study was to explore the...